Hjem › Kreft (alle typer) › North Carolina › Durham
Kliniske studier for Kreft (alle typer) i Durham, NC
58 studier for Kreft (alle typer) søker deltakere på steder i og rundt Durham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
RekruttererFase 1/2
- GSK Investigational Site, Durham
A Study of PHN-012 in Patients With Advanced Solid Tumors
RekruttererFase 1
- PHN-012-001 Site, Durham
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RekruttererObservasjonsstudie
- The University of North Carolina Chapel Hill, Chapel Hill · 10 mi unna
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekruttererFase 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 mi unna
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RekruttererFase 3
- Duke University Medical Center, Durham
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RekruttererFase 3
- Duke University Medical Center - Duke Cancer Centre, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruttererFase 3
- Quetzal Site 27, Chapel Hill · 10 mi unna
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi unna
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruttererFase 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekruttererFase 2/3
- Duke University Medical Center, Durham
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
Digital Art Therapy for Young Cancer Survivors
Rekrutterer
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
RekruttererFase 1
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill · 10 mi unna
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
RekruttererFase 1/2
- University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill · 10 mi unna
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruttererFase 1
- Duke Cancer Institute, Durham
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · 10 mi unna
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
RekruttererFase 3
- Duke Cancer Center, Durham
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
Rekrutterer
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RekruttererFase 3
- University of North Carolina Chapel Hill, Chapel Hill · 10 mi unna
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RekruttererFase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Duke University, Durham
Behavioral Pain Intervention for Older Cancer Patients
Rekrutterer
- Duke Cancer Network, Durham
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
RekruttererFase 1
- Duke Cancer Institute, Durham
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
RekruttererFrivillige helsepersonell ønskes velkommen
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
RekruttererFase 1/2
- University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill · 10 mi unna
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- University of North Carolina /ID# 251203, Chapel Hill · 10 mi unna
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RekruttererFase 2
- Duke University Medical Center /ID# 279457, Durham
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RekruttererFase 1
- Duke Cancer Center, Durham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Rekrutterer
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
RekruttererFrivillige helsepersonell ønskes velkommen
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10 mi unna
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekrutterer
- Durham VA Medical Center, Durham, NC, Durham
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
RekruttererObservasjonsstudie
- University of North Carolina, Chapel Hill · 10 mi unna
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekruttererFase 1
- Research Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekruttererFase 1
- Duke Cancer Center /ID# 251975, Durham
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
RekruttererFase 2
- Duke Comprehensive Cancer Center, Durham
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
Rekrutterer
- Durham VA Medical Center, Durham, NC, Durham
Improving Outcomes in Early Menopause After Cancer
Rekrutterer
- Duke Cancer Institute, Durham
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
RekruttererObservasjonsstudie
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors
RekruttererFrivillige helsepersonell ønskes velkommen
- Duke Cancer Institute, Durham
UNC Metastatic Cancer Radiation Therapy Registry
RekruttererObservasjonsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi unna
Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors
RekruttererObservasjonsstudie
- UNC Hospitals, Chapel Hill · 10 mi unna
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruttererFase 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Rekrutterer
- Durham VA Medical Center, Durham, NC, Durham
Rehabilitation Outcomes Study
Rekrutterer
- The N.C. Cancer Hospital, Chapel Hill · 10 mi unna
Cancer and Mild Cognitive Impairment Dyadic Intervention
Rekrutterer
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
RekruttererFase 2
- University of North Carolina /ID# 233313, Chapel Hill · 10 mi unna
GEMINI-NSCLC: NSCLC Biomarker Study
RekruttererObservasjonsstudie
- Duke University, Durham
- UNC, Chapel Hill · 10 mi unna
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Rekrutterer
- Duke Cancer Institute, Durham
Effectiveness of Central Oncology Navigation and the Use of an ORN
Rekrutterer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)
Rekrutterer
- Duke University School of Medicine, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi unna
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RekruttererObservasjonsstudie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi unna
Young Adult Infusion Space Experience Satisfaction Survey
RekruttererObservasjonsstudie
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
UNC Pleural Fluid Registry
RekruttererObservasjonsstudie
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
A Study of NX-1607 in Adults With Advanced Malignancies
RekruttererFase 1
- University of North Carolina, Chapel Hill · 10 mi unna
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekrutterer
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · 13 mi unna
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- New York City, NY109 studier
- Boston, MA85 studier
- Los Angeles, CA74 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Washington, DC58 studier
- Chicago, IL51 studier
- Atlanta, GA49 studier
- Seattle, WA49 studier
- Arlington, VA48 studier
- St. Louis, MO46 studier
Andre studier i Durham
- Brystkreft64 studier
- Ikke-småcellet lungekreft39 studier
- Multipelt myelom37 studier
- Akut myelogen leukemi33 studier
- Metastatisk kreft33 studier
- Prostatakreft32 studier
- Lungekreft32 studier
- Kolorektal kreft28 studier
- Eggstokkreft27 studier
- Kronisk lymfatisk leukemi27 studier
- Hjertesvikt26 studier
- Pankreaskreft24 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.